CervoMed Inc.CRVONASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P33
Within normal range
vs 5Y Ago
-0.4x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -3.57% |
| Q3 2025 | -20.00% |
| Q2 2025 | -25.00% |
| Q1 2025 | 27.27% |
| Q4 2024 | -40.00% |
| Q3 2024 | -103.70% |
| Q2 2024 | 34.15% |
| Q1 2024 | 2.38% |
| Q4 2023 | -164.62% |
| Q3 2023 | 141.94% |
| Q2 2023 | 48.50% |
| Q1 2023 | -0.33% |
| Q4 2022 | -76.47% |
| Q3 2022 | 44.81% |
| Q2 2022 | 7.51% |
| Q1 2022 | -30.08% |
| Q4 2021 | 71.49% |
| Q3 2021 | -223.02% |
| Q2 2021 | 33.97% |
| Q1 2021 | 11.53% |
| Q4 2020 | 8.48% |
| Q3 2020 | 28.96% |
| Q2 2020 | -31.65% |
| Q1 2020 | 33.85% |
| Q4 2019 | 81.24% |
| Q3 2019 | 5.64% |
| Q2 2019 | 22.20% |
| Q1 2019 | 51.66% |
| Q4 2018 | 15.54% |
| Q3 2018 | -142.92% |
| Q2 2018 | 80.04% |
| Q1 2018 | 0.00% |
| Q4 2017 | -100.00% |
| Q3 2017 | 116.32% |
| Q2 2017 | 53.75% |
| Q1 2017 | -1010.50% |
| Q4 2016 | 52.49% |
| Q3 2016 | -41.87% |
| Q2 2016 | 40.43% |
| Q1 2016 | 0.00% |